BACKGROUND: The development of accurate and precise folate assays has been difficult, mainly because of folate instability. Large interassay and interlaboratory differences have been reported. We therefore developed a serum folate assay that measures folate and putative degradation products as p-aminobenzoylglutamate (pABG) equivalents following oxidation and acid hydrolysis. METHODS: Serum was deproteinized with acid in the presence of 2 internal calibrators ([13C2]pABG and [13C5]5-methyltetrahydrofolate). 5-Methyltetrahydrofolate and other folate species in serum were converted to pABG by oxidation and mild acid hydrolysis. pABG and its internal calibrators were quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). RESULTS: The limit of quantification was 0.25 nmol/L, and the assay was linear in the range 0.25-96 nmol/L, which includes the 99.75 percentile for serum folate concentrations in healthy blood donors. Within- and between-day imprecision was < or = 5%. We detected no residual folate in serum samples after sample preparation. Folate concentrations in fresh serum samples obtained with the pABG assay and with a microbiologic assay showed good agreement (r = 0.96). In stored samples containing low folate concentrations due to folate degradation, the pABG assay yielded substantially higher folate concentrations than the microbiologic assay. CONCLUSIONS: The pABG assay combines automated sample preparation with LC-MS/MS analysis. It allows measurement of folate not only in fresh samples of serum/plasma but also in stored samples in which the folate has become oxidized and degraded to an extent that it cannot be assayed with traditional folate assays.
BACKGROUND: The development of accurate and precise folate assays has been difficult, mainly because of folate instability. Large interassay and interlaboratory differences have been reported. We therefore developed a serum folate assay that measures folate and putative degradation products as p-aminobenzoylglutamate (pABG) equivalents following oxidation and acid hydrolysis. METHODS: Serum was deproteinized with acid in the presence of 2 internal calibrators ([13C2]pABG and [13C5]5-methyltetrahydrofolate). 5-Methyltetrahydrofolate and other folate species in serum were converted to pABG by oxidation and mild acid hydrolysis. pABG and its internal calibrators were quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). RESULTS: The limit of quantification was 0.25 nmol/L, and the assay was linear in the range 0.25-96 nmol/L, which includes the 99.75 percentile for serum folate concentrations in healthy blood donors. Within- and between-day imprecision was < or = 5%. We detected no residual folate in serum samples after sample preparation. Folate concentrations in fresh serum samples obtained with the pABG assay and with a microbiologic assay showed good agreement (r = 0.96). In stored samples containing low folate concentrations due to folate degradation, the pABG assay yielded substantially higher folate concentrations than the microbiologic assay. CONCLUSIONS: The pABG assay combines automated sample preparation with LC-MS/MS analysis. It allows measurement of folate not only in fresh samples of serum/plasma but also in stored samples in which the folate has become oxidized and degraded to an extent that it cannot be assayed with traditional folate assays.
Authors: Cornelia M Ulrich; Mary Playdon; Rama Kiblawi; Andreana N Holowatyj; Biljana Gigic; Stefanie Brezina; Anne J M R Geijsen; Jennifer Ose; Tengda Lin; Sheetal Hardikar; Caroline Himbert; Christy A Warby; Jürgen Böhm; Martijn J L Bours; Fränzel J B van Duijnhoven; Tanja Gumpenberger; Dieuwertje E Kok; Janna L Koole; Eline H van Roekel; Petra Schrotz-King; Arve Ulvik; Andrea Gsur; Nina Habermann; Matty P Weijenberg; Per Magne Ueland; Martin Schneider; Alexis Ulrich Journal: Br J Nutr Date: 2020-02-05 Impact factor: 3.718
Authors: Kristin Wallace; Maria V Grau; A Joan Levine; Lanlan Shen; Randala Hamdan; Xinli Chen; Jiang Gui; Robert W Haile; Elizabeth L Barry; Dennis Ahnen; Gail McKeown-Eyssen; John A Baron; Jean Pierre J Issa Journal: Cancer Prev Res (Phila) Date: 2010-12
Authors: Jane C Figueiredo; A Joan Levine; Maria V Grau; Elizabeth L Barry; Per M Ueland; Dennis J Ahnen; Tim Byers; Robert S Bresalier; Robert W Summers; John Bond; Gail E McKeown-Eyssen; Robert S Sandler; Robert W Haile; John A Baron Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-10 Impact factor: 4.254
Authors: Alison J Price; Ruth C Travis; Paul N Appleby; Demetrius Albanes; Aurelio Barricarte Gurrea; Tone Bjørge; H Bas Bueno-de-Mesquita; Chu Chen; Jenny Donovan; Randi Gislefoss; Gary Goodman; Marc Gunter; Freddie C Hamdy; Mattias Johansson; Irena B King; Tilman Kühn; Satu Männistö; Richard M Martin; Klaus Meyer; David E Neal; Marian L Neuhouser; Ottar Nygård; Par Stattin; Grethe S Tell; Antonia Trichopoulou; Rosario Tumino; Per Magne Ueland; Arve Ulvik; Stefan de Vogel; Stein Emil Vollset; Stephanie J Weinstein; Timothy J Key; Naomi E Allen Journal: Eur Urol Date: 2016-04-06 Impact factor: 20.096
Authors: Kerry S Jones; Sarah R Meadows; Karen Chamberlain; Damon A Parkington; Dave Collins; Polly Page; Albert Koulman Journal: J Nutr Date: 2021-11-02 Impact factor: 4.798